Warning letter
Washington Homeopathic Products, Inc.: warning letter of Jun 19, 2020
FDA warning letter 589823 · Division of Pharmaceutical Quality Operations I
Key facts
| Reference number | 589823 |
|---|---|
| Company | Washington Homeopathic Products, Inc. |
| Subject | CGMP/Finished Pharmaceuticals/Adulterated |
| Issue date | Jun 19, 2020 |
| Posted date | Jul 7, 2020 |
| Issuing office | Division of Pharmaceutical Quality Operations I |
| Product type | Drugs |
| CFR sections cited | 211.22(a), 211.84(d)(1), 211.34, 211.165(e) |
| Inspection city | Berkeley Springs |
| Inspection ZIP | 25411 |
| Inspection start date | Jun 18, 2019 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: